Eclipse is pleased to announce the upcoming webinar, IDMP: What you need to know about July 2016, featuring panelist, Dr. Dieter Schlaps

November 23, 2015

Eclipse will host an upcoming IDMP Webinar: What you need to know about the July 2016 deadline, featuring panelist, Dr. Dieter Schlaps on December 10th, 2015 at 2:00PM EST. The webinar will address the EMEAs timeline for IDMP in a phased approach for implementation. Dr. Schlaps will be discussing the timelines and the proposed first iteration data fields. Also provided will be a worksheet for mapping your enterprise data to the prioritized fields to help kick start your IDMP initiative. The webinar will discuss why IDMP is crucial and how Health Authorities worldwide claim that despite the clear progress in the development of increasingly specific and complex drugs, there is an alarming steady increase in adverse reactions leading to large numbers of casualties around the globe. The FDA has recently published numbers that show there have been more than 700,000 emergency visits, more than 100,000 hospitalizations and around 100,000 deaths per year due to adverse events alone in the US. This is just one of the topics that will be discussed in the webinar for reasons why IDMP – as the future single source of truth – is so crucial for the mapping of terminologies used in the different health care systems worldwide and the cross-border identifiability of medicinal products and their components.

Eclipse is pleased to announce the addition of Dr. Dieter Schlaps to our team as a regulatory advisor with over 25 years of regulatory experience. He is currently a contributing member within the Workgroup 6 (“Pharmacy and Medicines Business”) of ISO’s Technical Committee 215 (“Health Informatics”) as a Delegate of DIN “Deutsches Institut fuer Normung”. Dr. Schlaps specializes in Regulatory Information and Document Management and has held management positions at IABG Ottobrunn, CSC Germany GmbH, Logica Germany and NNIT Germany GmbH. He has worked on customer projects at Heel, Astellas, Bayer AG, Merck KGaA, MSD, Boehringer Ingelheim, Takeda, Roche, Novartis, BASF AG, Abbott, Röhm Pharma, Almirall, Pfizer, Grünenthal, Novo Nordisk etc. He has also held lecturer positions in Health Economics, Medical Informatics, Pharmacoinformatics and Business Informatics at Universität der Bundeswehr Munich, University of Medical Informatics and Technology, Hall, Austria, and FOM Munich. Dr. Schlaps’ most recent projects include support for an IDMP Gap Analysis, Roadmap for a SharePoint-based solution.

To attend the webinar, please visit http://www.eclipsesol.com/clinical-technology/idmp-webinar

To learn more about Dr.Schlaps, please visit the company website.

About eclipse
Eclipse is a clinical technology company that partners with its clients to deliver the RIGHT Clinical technology solutions and Clinical data management services to ensure successful clinical trials. Eclipse is ISO9001:2008 registered, a testament to its commitment to providing products and services that meet customer and legal requirements. Eclipse partners with Oracle Health Services to help clients leverage best-in-class Clinical technology solutions. It also offers proprietary software and clinical services solutions, all with the aim of reducing risk, increasing speed and delivering quality results in clinical trials.

Eclipse is known for its unwavering commitment to client satisfaction. For more information visit www.eclipsesol.com

Eclipse proudly integrates with Oracle solutions

Oracle CRO AdvantageOracle Silver Partner